Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of a Randomized Multicenter Trial on Impact of Imatinib and Infliximab on Long-COVID in Hospitalized COVID-19 Patients

NCT05220280 is registered in ClinicalTrials.gov with Clinical Urology and Epidemiology Working Group as lead sponsor.

NCT NCT05220280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05220280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of a Randomized Multicenter Trial on Impact of Imatinib and Infliximab on Long-COVID in Hospitalized COVID-19 Patients
Lead sponsor
Clinical Urology and Epidemiology Working Group
Phase
Phase 4
Overall status
Unknown status
Start date
February 6, 2022
Completion date
December 31, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, covid19, sars-cov-2 acute respiratory disease